Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
U.S. FDA Approves Pfizer’s Adcetris Combination Regimen for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
(BUSINESS WIRE) February 12, 2025 -- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental...
FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)
February 12, 2025 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration...
FDA Approves Gomekli (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today...
FDA Approves Emblaveo (aztreonam and avibactam) for the Treatment of Adults With Complicated Intra-Abdominal Infections
AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved Emblaveo™ (aztreonam and avibactam), as the first...
Senators Call on FDA to Act Against Misleading Weight-Loss Drug Commercials
Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out advertisement of prescription...
Probiotics Linked to Reduced Mortality in Infants Born Before 34 Weeks
For infants born before 34 weeks of gestation and with a birth weight <1,000 g, probiotics used in neonatal units are associated with reduced mortality,...
Mortality Up for Individuals Who Need Hospital-Based Care for Cannabis Addiction
Individuals who require hospital-based care for cannabis use disorder (CUD) have an increased risk for premature death, according to a study published...
Overdiagnosis of Thyroid Cancer Persists
Overdiagnosis of thyroid cancer in the United States remains a persistent problem, according to a study published online Feb. 5 in The Lancet Diabetes...
In 2023, 1.4 Percent of U.S. Children Ever Experienced Post-COVID Condition
Post-COVID condition (PCC) continues to affect children, and 80 percent of those currently experiencing PCC have activity limitation, according to a research...
In People With Autism, ADHD Rates Still Common in Adulthood
Too often, ADHD and autism coincide in children. New research finds that for many of those kids, this dual diagnosis continues into adult life. Having...
Canned Tuna Recalled in Dozens of State Over Risk of Food Poisoning
A major recall of canned tuna sold in dozens of states has been issued amid concerns that a packaging defect could cause “a potentially fatal form...
Almost Half of Rural Americans Face Long Drives for Surgery
As closures of rural hospitals across the United States continue, more Americans are facing hour-plus drives to reach surgical centers, two new reports...
Single Dose of Broadly Neutralizing Antibody Protects Macaques from H5N1 Influenza
National Institutes of Health (NIH) scientists and their colleagues report that a single dose of a broadly neutralizing antibody (bnAb) administered prior...
NIH-Funded Clinical Trial Will Evaluate New Dengue Therapeutic
A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects...
Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmission...
Can GLP-1 Meds Harm Your Eyes?
Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight loss drugs, but the jury's out on whether the medications caused the...
Recently Added
Recently added consumer and prescribing information: Opdivo Qvantig, Alyftrek, Crenessity, Ensacove, Steqeyma, Yesintek, Revuforj, Danziten, Aucatzyl, Emrosi
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Gomekli Gomekli (mirdametinib) is a MEK inhibitor for the treatment of patients with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN).
- Emblaveo Emblaveo (aztreonam and avibactam) is a monobactam antibacterial and beta-lactamase inhibitor combination used for the treatment of...
- Onapgo Onapgo (apomorphine hydrochloride) is a continuous subcutaneous infusion formulation of the approved dopaminergic agonist apomorphine for...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...